M Ventures (Merck)
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
- United States
- Germany
- Israel
- United Kingdom
- Netherlands
- Switzerland
- China
Investment stages
- Seed
- Series A
- Growth
Industries
- Biotechnology
- Life Sciences
About
M Ventures is a global venture capital firm that invests in biotech, healthcare, and frontier technologies with strong strategic alignment to breakthrough scientific research. The firm targets innovative companies in therapeutics, diagnostics, materials science, and digital health, providing capital to help them scale from early-stage R&D to commercialization. M Ventures focuses on companies that have the potential to deliver transformative healthcare solutions and address some of the world’s most pressing scientific and technological challenges.
M Ventures is a global venture capital firm that invests in biotech, healthcare, and frontier technologies with strong strategic alignment to breakthrough scientific research. The firm targets innovative companies in therapeutics, diagnostics, materials science, and digital health, providing capital to help them scale from early-stage R&D to commercialization. M Ventures focuses on companies that have the potential to deliver transformative healthcare solutions and address some of the world’s most pressing scientific and technological challenges.
Investment Thesis
M Ventures’ thesis focuses on investing in breakthrough science and technology with the potential to transform global healthcare and industry. It targets companies in therapeutics, diagnostics, materials science, and frontier tech, leveraging its scientific network and long-term capital base to scale transformative innovation.
Manager's Experience
Managed by industry veterans focused on medical technology and healthcare innovation, combining clinical expertise with venture capital experience.
Team
Hakan Göker – Managing Director
Bio
Javier Rodriguez – Head
Technology Investments
Caroline Soulard – CFO
Ebru Uzun – Head of Business Ops
Portfolio
ImmuneBridge
Tignis
Outrun Therapeutics
MemryX
Calypso Biotech
beeOLED